Du, J.J.; Lai, F.; Váradi, L.; Williams, P.A.; Groundwater, P.W.; Platts, J.A.; Hibbs, D.E.; Overgaard, J.
Monoclinic Paracetamol vs. Paracetamol-4,4′-Bipyridine Co-Crystal; What Is the Difference? A Charge Density Study. Crystals 2018, 8, 46.
https://doi.org/10.3390/cryst8010046
AMA Style
Du JJ, Lai F, Váradi L, Williams PA, Groundwater PW, Platts JA, Hibbs DE, Overgaard J.
Monoclinic Paracetamol vs. Paracetamol-4,4′-Bipyridine Co-Crystal; What Is the Difference? A Charge Density Study. Crystals. 2018; 8(1):46.
https://doi.org/10.3390/cryst8010046
Chicago/Turabian Style
Du, Jonathan J., Felcia Lai, Linda Váradi, Peter A. Williams, Paul W. Groundwater, James A. Platts, David E. Hibbs, and Jacob Overgaard.
2018. "Monoclinic Paracetamol vs. Paracetamol-4,4′-Bipyridine Co-Crystal; What Is the Difference? A Charge Density Study" Crystals 8, no. 1: 46.
https://doi.org/10.3390/cryst8010046
APA Style
Du, J. J., Lai, F., Váradi, L., Williams, P. A., Groundwater, P. W., Platts, J. A., Hibbs, D. E., & Overgaard, J.
(2018). Monoclinic Paracetamol vs. Paracetamol-4,4′-Bipyridine Co-Crystal; What Is the Difference? A Charge Density Study. Crystals, 8(1), 46.
https://doi.org/10.3390/cryst8010046